Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-16 09:50 am Purchase | 2024-12-13 | 13D | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 7,216,312 8.500% | 1,614,233 (+28.81%) | Filing History |
| 2024-11-15 10:34 am Sale | 2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 5,441,896 6.400% | -1,553,965 (-22.21%) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 6,618,297 7.839% | 1,267,638 (+23.69%) | Filing History |
| 2024-02-15 11:35 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 09:15 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:02 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 6,995,861 8.400% | 811,000 (+13.11%) | Filing History |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | Atea Pharmaceuticals, Inc. AVIR | VANGUARD GROUP INC | 4,599,710 5.510% | -1,489,812 (-24.47%) | Filing History |
| 2024-02-13 4:30 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 8,162,914 9.600% | 688,032 (+9.20%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 5,350,659 6.412% | -1,723,628 (-24.36%) | Filing History |
| 2024-02-07 09:25 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 0 (Unchanged) | Filing History |
| 2024-02-07 09:14 am Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 1,418,434 (+33.90%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 9,443,887 11.300% | 605,872 (+6.86%) | Filing History |
| 2023-11-28 06:00 am Purchase | 2023-11-22 | 13D | Atea Pharmaceuticals, Inc. AVIR | TANG CAPITAL PARTNERS LP | 4,033,463 4.800% | 1,007,008 (+33.27%) | Filing History |
| 2023-11-07 3:33 pm Purchase | 2023-10-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | BlackRock Inc. BLK | 8,838,015 10.600% | 804,443 (+10.01%) | Filing History |
| 2023-10-02 11:45 am Purchase | 2023-09-25 | 13G | Atea Pharmaceuticals, Inc. AVIR | BML Investment Partners, L.P. | 4,183,645 5.000% | 4,183,645 (New Position) | Filing History |
| 2023-09-11 08:23 am Sale | 2023-09-08 | 13G | Atea Pharmaceuticals, Inc. AVIR | FMR LLC | 7,074,287 8.482% | -4,663,122 (-39.73%) | Filing History |
| 2023-05-22 09:00 am Purchase | 2023-05-22 | 13D | Atea Pharmaceuticals, Inc. AVIR | TANG CAPITAL PARTNERS LP | 3,026,455 3.600% | 3,026,455 (New Position) | Filing History |
| 2023-02-10 4:15 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 7,474,882 8.800% | 374,883 (+5.28%) | Filing History |
| 2023-02-10 1:37 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 6,184,861 7.400% | 808,727 (+15.04%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Atea Pharmaceuticals, Inc. AVIR | VANGUARD GROUP INC | 6,089,522 7.310% | 307,640 (+5.32%) | Filing History |